Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis’ Cell-based Vaccine: Seasonal Approval With Pandemic Implications

This article was originally published in The Pink Sheet Daily

Executive Summary

The Flucelvax flu vaccine is the first approved in the U.S. that is derived from cell-based technology instead of the traditional egg-based process. It will be made at Novartis’ Holly Springs, N.C. plant.

You may also be interested in...



Flu Vaccines Likely To Remain Immune From Comparative Effectiveness

CDC’s Advisory Committee on Immunization Practices adds four recently-approved flu vaccines to its recommended list of products, but the committee chair expresses doubt that there could ever be data to make preferential recommendations.

Drug Shortages: FDA Wants Ideas To Boost Manufacturing Quality For Strategic Plan

Agency asks for comments to help it formulate a strategic plan to mitigate and prevent drug shortages, including ideas for incentives to increase manufacturing capacity and promote increased quality.

Protein Sciences To Begin Selling Novel Flu Vaccine; Flublok Has Virus-Free Appeal

The trivalent vaccine can be produced much faster than traditional vaccines and could be modified to compete with quadrivalent formulations.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM004674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel